136 related articles for article (PubMed ID: 19864957)
1. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana.
Chen JY; Ogwu AC; Svab P; Lockman S; Moffat HJ; Gaolathe T; Moilwa S; Størdal K; Dryden-Peterson S; Moffat C; Makhema J; Essex M; Shapiro RL
J Acquir Immune Defic Syndr; 2010 May; 54(1):102-6. PubMed ID: 19864957
[TBL] [Abstract][Full Text] [Related]
2. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
4. Evolving care of HIV-infected pregnant women in Jamaica--from nevirapine to HAART.
Johnson N; Palmer P; Samuels LA; Morgan O; Onyonyor A; Anderson M; Moore J; Billings C; Harvey KM; Mullings A; McDonald D; Alexander G; Smikle MF; Williams EW; Davis D; Christie CD
West Indian Med J; 2008 Jun; 57(3):216-22. PubMed ID: 19583119
[TBL] [Abstract][Full Text] [Related]
5. High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.
Powis KM; McElrath TF; Hughes MD; Ogwu A; Souda S; Datwyler SA; von Widenfelt E; Moyo S; Nádas M; Makhema J; Machakaire E; Lockman S; Essex M; Shapiro RL
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):517-24. PubMed ID: 23344545
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
7. Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.
Hussain A; Moodley D; Naidoo S; Esterhuizen TM
PLoS One; 2011; 6(12):e27907. PubMed ID: 22162993
[TBL] [Abstract][Full Text] [Related]
8. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
Mnyani CN; McIntyre JA; Myer L
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.
Chen JY; Ribaudo HJ; Souda S; Parekh N; Ogwu A; Lockman S; Powis K; Dryden-Peterson S; Creek T; Jimbo W; Madidimalo T; Makhema J; Essex M; Shapiro RL
J Infect Dis; 2012 Dec; 206(11):1695-705. PubMed ID: 23066160
[TBL] [Abstract][Full Text] [Related]
11. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.
Wester CW; Kim S; Bussmann H; Avalos A; Ndwapi N; Peter TF; Gaolathe T; Mujugira A; Busang L; Vanderwarker C; Cardiello P; Johnson O; Thior I; Mazonde P; Moffat H; Essex M; Marlink R
J Acquir Immune Defic Syndr; 2005 Nov; 40(3):336-43. PubMed ID: 16249709
[TBL] [Abstract][Full Text] [Related]
12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
13. An augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trial.
Dryden-Peterson S; Bennett K; Hughes MD; Veres A; John O; Pradhananga R; Boyer M; Brown C; Sakyi B; van Widenfelt E; Keapoletswe K; Mine M; Moyo S; Asmelash A; Siedner M; Mmalane M; Shapiro RL; Lockman S
PLoS One; 2015; 10(2):e0117181. PubMed ID: 25693050
[TBL] [Abstract][Full Text] [Related]
14. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
[TBL] [Abstract][Full Text] [Related]
15. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
[TBL] [Abstract][Full Text] [Related]
16. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.
Carter RJ; Dugan K; El-Sadr WM; Myer L; Otieno J; Pungpapong N; Toro PL; Abrams EJ;
J Acquir Immune Defic Syndr; 2010 Nov; 55(3):404-10. PubMed ID: 20595905
[TBL] [Abstract][Full Text] [Related]
17. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
Darak S; Darak T; Kulkarni S; Kulkarni V; Parchure R; Hutter I; Janssen F
AIDS Patient Care STDS; 2013 Mar; 27(3):163-70. PubMed ID: 23477457
[TBL] [Abstract][Full Text] [Related]
18. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
19. Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.
Ekouevi DK; Inwoley A; Tonwe-Gold B; Danel C; Becquet R; Viho I; Rouet F; Dabis F; Anglaret X; Leroy V
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1469-74. PubMed ID: 18160003
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.
Shapiro RL; Souda S; Parekh N; Binda K; Kayembe M; Lockman S; Svab P; Babitseng O; Powis K; Jimbo W; Creek T; Makhema J; Essex M; Roberts DJ
PLoS One; 2012; 7(2):e31580. PubMed ID: 22384039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
